GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Devonian Health Group Inc (TSXV:GSD) » Definitions » Cyclically Adjusted Price-to-FCF

Devonian Health Group (TSXV:GSD) Cyclically Adjusted Price-to-FCF : (As of Jun. 05, 2025)


View and export this data going back to 2014. Start your Free Trial

What is Devonian Health Group Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Devonian Health Group Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Devonian Health Group's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Devonian Health Group Cyclically Adjusted Price-to-FCF Chart

Devonian Health Group Annual Data
Trend Jun15 Jun16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Devonian Health Group Quarterly Data
Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Devonian Health Group's Cyclically Adjusted Price-to-FCF

For the Biotechnology subindustry, Devonian Health Group's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Devonian Health Group's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Devonian Health Group's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Devonian Health Group's Cyclically Adjusted Price-to-FCF falls into.


;
;

Devonian Health Group Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Devonian Health Group's Cyclically Adjusted FCF per Share for the quarter that ended in Jan. 2025 is calculated as:

For example, Devonian Health Group's adjusted Free Cash Flow per Share data for the three months ended in Jan. 2025 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Jan. 2025 (Change)*Current CPI (Jan. 2025)
=-0.013/127.4427*127.4427
=-0.013

Current CPI (Jan. 2025) = 127.4427.

Devonian Health Group Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201503 -0.003 99.789 -0.004
201506 -0.001 100.500 -0.001
201509 -0.032 100.421 -0.041
201512 -0.030 99.947 -0.038
201603 -0.012 101.054 -0.015
201606 -0.027 102.002 -0.034
201609 -0.001 101.765 -0.001
201612 -0.002 101.449 -0.003
201703 0.000 102.634 0.000
201707 0.000 103.029 0.000
201710 -0.008 103.424 -0.010
201801 -0.011 104.056 -0.013
201804 -0.008 105.320 -0.010
201807 -0.008 106.110 -0.010
201810 -0.015 105.952 -0.018
201901 0.010 105.557 0.012
201904 -0.013 107.453 -0.015
201907 -0.001 108.243 -0.001
201910 -0.011 107.927 -0.013
202001 0.001 108.085 0.001
202004 -0.003 107.216 -0.004
202007 -0.014 108.401 -0.016
202010 -0.007 108.638 -0.008
202101 -0.008 109.192 -0.009
202104 -0.003 110.851 -0.003
202107 -0.003 112.431 -0.003
202110 -0.005 113.695 -0.006
202201 -0.005 114.801 -0.006
202204 -0.004 118.357 -0.004
202207 -0.009 120.964 -0.009
202210 -0.009 121.517 -0.009
202301 -0.008 121.596 -0.008
202304 -0.006 123.571 -0.006
202307 -0.008 124.914 -0.008
202310 -0.004 125.310 -0.004
202401 -0.003 125.072 -0.003
202404 0.001 126.890 0.001
202407 0.043 128.075 0.043
202410 0.018 127.838 0.018
202501 -0.013 127.443 -0.013

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Devonian Health Group  (TSXV:GSD) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Devonian Health Group Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Devonian Health Group's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Devonian Health Group Business Description

Traded in Other Exchanges
Address
360, Rue des Entrepreneurs, Montmagny, QC, CAN, G5V 4T1
Devonian Health Group Inc is operating in the pharmaceutical sector. It is engaged in the development and distribution of botanical drugs. The group is also involved in the development of value-added products for dermo-cosmetics. It has established a research effort focused on the anticipation of new solutions in the medical sector as well as in the cosmetic sector. The company's technology platform, The Supra Molecular Complex Extraction and Stabilization Technology provides a process of extraction, purification, stabilization, and conditioning of molecular complexes, as active botanical ingredients, from plants and algae. Its product portfolio includes pharmaceuticals like Thykamine, Pantoprazole, and Cleo-35; and cosmeceutical products like R-Spinasome and Purgenesis.

Devonian Health Group Headlines

No Headlines